首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Problems in determining thalassemia carrier status in a program for prevention and control of severe thalassemia syndromes: A lesson from Thailand
【24h】

Problems in determining thalassemia carrier status in a program for prevention and control of severe thalassemia syndromes: A lesson from Thailand

机译:预防和控制严重地中海贫血综合征的方案中确定地中海贫血携带者状况的问题:泰国的经验教训

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Prevention and control of severe β thalassemia by carrier detection and identification of couples at risk in developed countries is one of the most successful stories in modern medicine. Similar programs in developing countries especially Southeast Asia, are more problematic because both α and β thalassemias are highly prevalent. In Thailand, there are limited data on whether we could determine, based on hematological phenotypes, the mutation severity and/or coinheritance of α thalassemia in β thalassemia traits. Methods: Comprehensive molecular, hematology and hemoglobin analyses of the α and β globin genes were performed in 141 healthy individuals identified as β thalassemia carriers. Results: Seventeen different β globin mutations were successfully identified out of all cases analyzed. Although the majority of the mutations identified were the β0 or severe β+ thalassemia alleles, a high proportion of mild mutations (25%) was observed. Of these β thalassemia traits, 22.3% were found to co-inherit the α thalassemias. Milder hematological phenotypes were noted in β+ compared with β0 thalassemia traits when the α globin genes were intact. Although co-inheritance of α0 thalassemia might be suspected in cases with skewed profiles, due to the overlapping values, it remains difficult to apply these parameters for reliable carrier determination. Conclusions: A combination of hemoglobin analysis and DNA testing seems to be the best way to confirm carrier status in a region with high frequency for both α and β thalassemias. Underdiagnoses of carrier status could hamper the effectiveness of a thalassemia prevention and control program.
机译:背景:在发达国家,通过携带者检测和识别处于危险中的夫妇来预防和控制严重的β地中海贫血是现代医学中最成功的故事之一。在发展中国家,尤其是东南亚,类似的计划存在更多问题,因为α和β地中海贫血都非常普遍。在泰国,关于能否根据血液学表型确定β地中海贫血性状中α地中海贫血的突变严重性和/或共遗传性的数据有限。方法:对141名被确定为β地中海贫血携带者的健康个体进行了α和β珠蛋白基因的全面分子,血液学和血红蛋白分析。结果:在所有分析病例中成功鉴定出17种不同的β珠蛋白突变。尽管鉴定出的大多数突变是β0或严重的β+地中海贫血等位基因,但观察到高比例的轻度突变(25%)。在这些β地中海贫血特征中,发现22.3%可以共同继承α地中海贫血。当α珠蛋白基因完好无损时,与β0地中海贫血相比,β+的血液学表型较轻。尽管在轮廓偏斜的情况下可能会怀疑α0地中海贫血的共遗传性,但由于重叠的值,仍然难以应用这些参数来确定可靠的载体。结论:血红蛋白分析和DNA检测相结合似乎是确认高频率地区α和β地中海贫血携带者状态的最佳方法。携带者状况的误诊可能会妨碍地中海贫血预防和控制计划的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号